Latest News

Renishaw Announces Completion of the Main Part of a Multi-Centre Clinical Trial Jointly Undertaken with Herantis Pharma plc for the Treatment of Parkinson’s Disease Patients

Renishaw, announces that its drug delivery device has played a critical role in the investigation CDNF as a treatment for Parkinson’s disease.

Source link

Related posts

Deaths from cardiovascular disease have risen by 4 percent in the last 5 years


Medical News Today: Study outlines concerns around natural psychoactive substances


ViiV Healthcare soumet une application réglementaire auprès de l’Agence européenne des médicaments pour fostemsavir, un inhibiteur de fixation de premier rang pour le traitement du VIH chez les adultes ayant peu d’options thérapeutiques disponibles


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy